Boston Business Journal |
Former Novartis exec to lead Cambridge diabetes startup Semma
Boston Business Journal A former Novartis executive who helped lead the pharma giant's development of cell-based medicines has been named CEO of Semma Therapeutics, a Cambridge-based startup that is developing a diabetes treatment derived from stem cells. Semma announced ... Hunting a cure, Ex-Novartis exec Bastiano Sanna takes the reins at Cambridge diabetes startup Semma |
from diabetes - Google News
Social Plugin